WEC
BIIB icon

Winslow Evans & Crocker’s Biogen BIIB Stock Holding History

Winslow Evans & Crocker’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$397K Buy
1,622
+69
+4% +$17.8K 0.08% 224
2020
Q3 		$441K Hold
1,553
– – 0.11% 179
2020
Q2 		$416K Sell
1,553
-1
-0.1% -$301 0.11% 176
2020
Q1 		$492K Sell
1,554
-26
-2% -$7.89K 0.16% 131
2019
Q4 		$470K Sell
1,580
-10
-0.6% -$2.77K 0.12% 179
2019
Q3 		$372K Hold
1,590
– – 0.1% 202
2019
Q2 		$372K Sell
1,590
-4
-0.3% -$924 0.1% 206
2019
Q1 		$378K Buy
1,594
+14
+0.9% +$4.41K 0.11% 198
2018
Q4 		$476K Hold
1,580
– – 0.16% 142
2018
Q3 		$560K Hold
1,580
– – 0.17% 137
2018
Q2 		$460K Hold
1,580
– – 0.14% 151
2018
Q1 		$433K Hold
1,580
– – 0.14% 145
2017
Q4 		$503K Sell
1,580
-12
-0.8% -$3.85K 0.16% 136
2017
Q3 		$498K Sell
1,592
-30
-2% -$8.88K 0.17% 135
2017
Q2 		$440K Hold
1,622
– – 0.12% 189
2017
Q1 		$443K Hold
1,622
– – 0.14% 157
2016
Q4 		$460K Hold
1,622
– – 0.14% 154
2016
Q3 		$508K Hold
1,622
– – 0.15% 148
2016
Q2 		$392K Sell
1,622
-20
-1% -$5.27K 0.12% 176
2016
Q1 		$427K Hold
1,642
– – 0.13% 158
2015
Q4 		$503K Sell
1,642
-176
-10% -$50.6K 0.14% 152
2015
Q3 		$530K Buy
1,818
+176
+11% +$58.1K 0.17% 134
2015
Q2 		$663K Hold
1,642
– – 0.19% 130
2015
Q1 		$693K Sell
1,642
-250
-13% -$98.5K 0.2% 116
2014
Q4 		$642K Buy
1,892
+44
+2% +$14.2K 0.18% 124
2014
Q3 		$611K Sell
1,848
-17
-0.9% -$5.61K 0.18% 133
2014
Q2 		$588K Sell
1,865
-606
-25% -$182K 0.19% 132
2014
Q1 		$756K Hold
2,471
– – 0.26% 93
2013
Q4 		$691K Buy
+2,471
New +$639K 0.24% 102

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Winslow Evans & Crocker's BIIB Position: Q4 2020 in Review

Winslow Evans & Crocker increased its Biogen (BIIB) stake by 4.4% in Q4 2020, buying an estimated $17.8K and bringing the position to 1,622 shares worth $397K. The position accounts for 0.08% of the portfolio, ranked #224.

Winslow Evans & Crocker first reported a position in BIIB in Q4 2013 and has held it in 29 quarters since. The position peaked at $756K in Q1 2014. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Winslow Evans & Crocker held 1,622 shares of Biogen worth $397K as of Q4 2020.
  • Winslow Evans & Crocker bought 69 Biogen shares in Q4 2020, an estimated $17.8K.
  • Biogen made up 0.08% of Winslow Evans & Crocker's portfolio in Q4 2020, its #224 holding.
  • Winslow Evans & Crocker first reported a position in Biogen in Q4 2013 and has held it in 29 quarters since.
  • Winslow Evans & Crocker's Biogen position peaked at $756K in Q1 2014.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.